• About us
    • Mission
    • Strategy
    • History
    • Our facility
    • Financial results
    • Leadership Team
    • Scientific Board
    • Supervisory Board
  • Our science
    • Autoimmunology
    • Cell therapies
    • Pipeline
    • Publications
  • Patients
    • About therapy
    • Our experience
    • Important information
    • Q&As
    • Contact
  • Partners
  • News & Media
  • Career
  • Contact
Search 
  • ENG
    • PL

2020-11-01

November 2020

Czech Liaison Office for Research, Development and Innovation (CZELO) distinguished our project as the example of good practice realized with the support from Horizon 2020 by the company from Visegrad countries (see page 58 of the brochure)

Link

https://cordis.europa.eu/project/id/830559

Download PDF

https://poltreg.com/wp-content/uploads/2020/12/CZELO-V4-Brochure-H2020-Good-Practice.pdf

See other news

2025-07-04

World-Class Experts Join Immuthera’s Scientific Advisory Board

See

2025-06-20

PolTREG at  BIO International Convention 2025

See

2025-06-13

PolTREG Establishes U.S. Subsidiary Immuthera to Advance International Development Strategy

See

2025-05-14

PolTREG Q1 2025 financial results webinar

See

2025-04-23

PolTREG accelerates the development of next-generation antigen-specific Tregtherapy for Type 1 Diabetes

See

2025-04-18

PolTREG Expands U.S. Market Presence with New Kubera N.A. LLC Collaboration

See

2025-03-27

PolTREG partners with Noble Capital Markets Inc. to prepare for potential fundraising in the U.S.

See

2025-03-25

Webinar: PolTREG’s Strategic Collaboration with Antion Biosciences and Growth Prospects for 2025

See

PolTREG S.A.
Botaniczna 20, 80-298 Gdańsk

Contact

office@poltreg.com +48 512 532 401

Follow us

f in

About Us

  • History
  • Strategy
  • Our facility
  • Financial results
  • Leadership Team
  • Scientific Board
  • Supervisory Board

Partners

Our Science

  • Autoimmunology
  • Cell therapies
  • Pipeline
  • Publications

News & Media

Patients

  • About therapy
  • Our experience
  • Important information
  • Q&As
  • Contact

Partners

News & Media

© 2025 by PolTREG
GDPR
Cookie policy
Design by fluostudio